Europe's PRAC concludes ambroxol risk is "small"

15 January 2015 - Deborah Wilkes

The risk of allergic reactions to medicines containing ambroxol or bromhexine is "small", the European Union's Pharmacovigilance Risk Assessment Committee (PRAC) has concluded following a safety review.